NASDAQ:ABUS
$2.93
(
0%
)
Friday, 27th Jan 2023
Arbutus Biopharma Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.15 | $2.97 | Friday, 27th Jan 2023 ABUS stock ended at $2.93. During the day the stock fluctuated 2.77% from a day low at $2.89 to a day high of $2.97. |
| 90 days | $2.15 | $2.97 | |
| 52 weeks | $1.85 | $3.64 |
Historical Arbutus Biopharma Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $2.92 | $2.97 | $2.89 | $2.93 | 659 950 |
| 2023-01-26 | $2.88 | $2.96 | $2.86 | $2.93 | 409 583 |
| 2023-01-25 | $2.79 | $2.94 | $2.79 | $2.87 | 1 406 304 |
| 2023-01-24 | $2.77 | $2.80 | $2.72 | $2.78 | 306 941 |
| 2023-01-23 | $2.79 | $2.79 | $2.68 | $2.76 | 379 050 |
| 2023-01-20 | $2.68 | $2.76 | $2.65 | $2.76 | 619 003 |
| 2023-01-19 | $2.60 | $2.68 | $2.60 | $2.64 | 351 850 |
| 2023-01-18 | $2.83 | $2.84 | $2.65 | $2.65 | 579 208 |
| 2023-01-17 | $2.83 | $2.89 | $2.76 | $2.80 | 548 800 |
| 2023-01-13 | $2.87 | $2.93 | $2.82 | $2.85 | 668 774 |
| 2023-01-12 | $2.70 | $2.87 | $2.67 | $2.87 | 1 512 700 |
| 2023-01-11 | $2.74 | $2.82 | $2.68 | $2.69 | 730 300 |
| 2023-01-10 | $2.68 | $2.80 | $2.65 | $2.75 | 1 011 300 |
| 2023-01-09 | $2.52 | $2.75 | $2.51 | $2.67 | 1 949 322 |
| 2023-01-06 | $2.29 | $2.55 | $2.27 | $2.51 | 1 885 100 |
| 2023-01-05 | $2.23 | $2.28 | $2.15 | $2.26 | 851 452 |
| 2023-01-04 | $2.28 | $2.28 | $2.22 | $2.26 | 383 179 |
| 2023-01-03 | $2.35 | $2.40 | $2.22 | $2.23 | 719 689 |
| 2022-12-30 | $2.28 | $2.36 | $2.26 | $2.33 | 1 921 678 |
| 2022-12-29 | $2.22 | $2.34 | $2.22 | $2.32 | 824 069 |
| 2022-12-28 | $2.31 | $2.35 | $2.20 | $2.22 | 1 267 322 |
| 2022-12-27 | $2.39 | $2.39 | $2.26 | $2.33 | 1 242 376 |
| 2022-12-23 | $2.39 | $2.40 | $2.33 | $2.39 | 485 400 |
| 2022-12-22 | $2.42 | $2.42 | $2.32 | $2.41 | 765 421 |
| 2022-12-21 | $2.40 | $2.43 | $2.35 | $2.40 | 889 192 |
| 2022-12-20 | $2.44 | $2.44 | $2.32 | $2.42 | 844 179 |
| 2022-12-19 | $2.71 | $2.71 | $2.41 | $2.42 | 985 243 |
| 2022-12-16 | $2.70 | $2.80 | $2.61 | $2.71 | 3 072 962 |
| 2022-12-15 | $2.66 | $2.76 | $2.65 | $2.71 | 1 118 992 |
| 2022-12-14 | $2.67 | $2.79 | $2.62 | $2.72 | 1 182 910 |
| 2022-12-13 | $2.71 | $2.81 | $2.60 | $2.67 | 877 664 |
| 2022-12-12 | $2.61 | $2.77 | $2.59 | $2.71 | 667 697 |
| 2022-12-09 | $2.72 | $2.73 | $2.61 | $2.61 | 648 296 |
| 2022-12-08 | $2.58 | $2.75 | $2.56 | $2.72 | 737 856 |
| 2022-12-07 | $2.46 | $2.61 | $2.46 | $2.57 | 546 255 |
| 2022-12-06 | $2.44 | $2.55 | $2.42 | $2.45 | 958 410 |
| 2022-12-05 | $2.45 | $2.55 | $2.38 | $2.43 | 519 967 |
| 2022-12-02 | $2.30 | $2.51 | $2.26 | $2.48 | 1 012 764 |
| 2022-12-01 | $2.37 | $2.45 | $2.30 | $2.33 | 1 192 009 |
| 2022-11-30 | $2.40 | $2.49 | $2.31 | $2.35 | 1 376 575 |
| 2022-11-29 | $2.56 | $2.64 | $2.39 | $2.39 | 1 035 412 |
| 2022-11-28 | $2.66 | $2.74 | $2.53 | $2.58 | 1 105 464 |
| 2022-11-25 | $2.71 | $2.71 | $2.66 | $2.67 | 151 547 |
| 2022-11-23 | $2.66 | $2.80 | $2.66 | $2.70 | 635 979 |
| 2022-11-22 | $2.68 | $2.71 | $2.64 | $2.66 | 411 478 |
| 2022-11-21 | $2.77 | $2.83 | $2.62 | $2.64 | 840 081 |
| 2022-11-18 | $2.87 | $2.87 | $2.73 | $2.84 | 931 367 |
| 2022-11-17 | $2.68 | $2.89 | $2.64 | $2.79 | 1 094 533 |
| 2022-11-16 | $2.85 | $2.91 | $2.70 | $2.71 | 1 313 581 |
| 2022-11-15 | $2.70 | $2.84 | $2.64 | $2.76 | 1 288 250 |
About Arbutus Biopharma Corporation
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
